Jaguar Health Inc (NASDAQ:JAGX)’s share price fell 6.7% during trading on Monday . The stock traded as low as $0.14 and last traded at $0.14. 3,437,101 shares traded hands during trading, a decline of 49% from the average session volume of 6,710,850 shares. The stock had previously closed at $0.15.
Separately, ValuEngine upgraded shares of Jaguar Health from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.
The company has a quick ratio of 0.15, a current ratio of 0.26 and a debt-to-equity ratio of 0.35.
Jaguar Health Company Profile
Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.